source
- Four major drugmakers allegedly paid tens of millions to Russian middlemen for lifesaving drugs, limiting patient accessFour large pharmaceutical companies are accused of funneling tens of millions of dollars to Russian intermediaries to deliver essential medicines to government agencies, according to a report by th…
- Kymera Therapeutics to unveil mid‑stage eczema trial data, aiming to challenge DupixentKymera Therapeutics, a Massachusetts‑based biotech, is set to release data from its mid‑stage clinical trial of KT‑621 in eczema before the end of 2026. The trial results are being closely watched…